Preparation and proteolytic degradation of a macromolecular prot

Chemistry: molecular biology and microbiology – Micro-organism – tissue cell culture or enzyme using process... – Enzymatic production of a protein or polypeptide

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

530350, 530417, C12P 2106, C07K 112, C07K 14745

Patent

active

056078412

ABSTRACT:
A method for preparing a macromolecular protein complex (MPC) from fibrinogen in human plasma by the steps of ammonium sulfate precipitation, dialysis and gel filtration is disclosed. The isolated MPC may be degraded by contacting with trypsin. The isolated MPC inhibited fibrinolysis induced with plasminogen but not with plasmin. Elimination of the MPC by means of chondroitin sulfate A restored normal fibrinolysis. An antibody to fibrin-binding peptides which are produced by trypsin degradation of MPC, was conjugated to plasmin. The anti-MPC peptide antibody/plasmin conjugate has the capacity to bind to MPC-rich thrombus and degrade it without activation of fibrin-bound plasminogen.

REFERENCES:
patent: 3895107 (1975-07-01), Morrison
patent: 4381346 (1983-04-01), Hussin et al.
patent: 4602005 (1986-07-01), Malinow
patent: 4673573 (1987-06-01), Ferres et al.
patent: 5004802 (1991-04-01), Kluft
patent: 5011686 (1991-04-01), Pang
patent: 5089602 (1992-02-01), Isliker et al.
patent: 5096696 (1992-03-01), Galanakis
patent: 5116613 (1992-05-01), Haber et al.
patent: 5261255 (1993-11-01), Coelho et al.
patent: 5290915 (1994-03-01), Nakao et al.
Brewer et al. (1974) "Experimental Techniques in Biochemistry", Prentice-Hall, Inc., Englewood Cliffs, pp. 325-328.
Sigma (1992) "Biochemicals and Organic Compounds" (Catalog), p. 1574.
Sobel et al., "Monoclonal Antibody to the Region of Fibronectin Involved in Cross-linking to Human Fibrin", Biochemistry, vol. 22, pp. 4175-4183 (1983).
Bisbee, C. A., "Development of Thrombolytic Therapeutics and Lessons Learned from tPA", Genetic Engineering News, Dec. 1993, p. 10.
Phaneuf et al., "Covalent Linkage of Streptokinase to Recombinant Hirudin: A novel thrombolytic Agent with Antithrombotic Properties", Thrombos. Haemost. vol. 71, pp. 481-487 (1994).
Shohet et al., "Inhibitor-resistant Tissue-type Plasminogen Activator: An Improved Thrombolytic Agent In Vitro", Thrombos. Haemost. vol. 71, pp. 124-128 (1994).
Takada et al., "Effects of Heparin Sulfate Analogue or Other Sulfated Polysaccharides on the Activation of Plasminogen by t-PA or u-PA", Thrombos. Res. vol. 73, pp. 301-311 (1994).

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Preparation and proteolytic degradation of a macromolecular prot does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Preparation and proteolytic degradation of a macromolecular prot, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Preparation and proteolytic degradation of a macromolecular prot will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-2145409

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.